Cnbc
@cnbc·4.2M subscribers·16.1K videos
Eli Lilly Alzheimer's Drug Does Not Slow Memory Loss | Squawk Box | CNBC
Posted
November 23, 2016
Views
3,708
Likes
8
Comments
4
Engagement
0.32%
November 23, 2016
3,708
8
4
0.32%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
Lilly shares tumble after its Alzheimer drug study did not meet its goals, reports CNBC's Meg Tirrell. Obviously we are disappointed but we remain committed to Alzheimer's disease, says John Lechleiter, Eli Lilly CEO. And David Ricks, Eli Lilly incoming CEO, weighs in on the company's future growth prospects.
» Subscribe to CNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news
Find CNBC News on Facebook
Follow CNBC News on Twitter
Follow CNBC News on Google+
Follow CNBC News on Instagram
Eli Lilly Alzheimer's Drug Does Not Slow Memory Loss | Squawk Box | CNBC
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
